PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
6203365-6	1984	The findings strongly suggest a non-cytotoxic secretory process requiring the presence of two quaternary ammonium groups as suggested by the rarity of release with tubocurarine; inhibition of succinyldicholine (suxamethonium)-induced histamine release by serum cholinesterase treatment, acetylcholine and tubocurarine; and the bell-shaped dose-response curve, particularly with suxamethonium.	quaternary ammonium	94-113	butyrylcholinesterase	Homo sapiens	261-275	
14331249-0	1965	[PROTECTION EXERCISED BY CHOLINESTERASE INHIBITORS WITH 1 OR 2 QUATERNARY AMMONIUM FUNCTIONS AGAINST THE INHIBITORY CAPACITY OF PROSTIGMINE].	quaternary ammonium	63-82	butyrylcholinesterase	Homo sapiens	25-39	
9671522-0	1998	Trp82 and Tyr332 are involved in two quaternary ammonium binding domains of human butyrylcholinesterase as revealed by photoaffinity labeling with [3H]DDF.	quaternary ammonium	37-56	butyrylcholinesterase	Homo sapiens	82-103	
9671522-9	1998	This labeling study establishes the existence of two different binding domains for quaternary ammonium in BuChE and exemplifies additional cation/pi interactions in cholinergic proteins.	quaternary ammonium	83-102	butyrylcholinesterase	Homo sapiens	106-111